Save your place

Sign in to WhoBought

Please try again later.

Bright Minds Biosciences Inc. (DRUG) institutional ownership

Latest close $74.61 Jul 20, 2026
Market cap$668M 52-week range SectorHealthcare
Funds holding · Q1 2026
93
reported DRUG position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
71 buyers · 22 sellers

Bright Minds Biosciences Inc. (DRUG) price and institutional activity

Dates

Q1 2026

$0 bought by 71 investors
Vestal Point Capital, LPDeerfield Management Company, L.P. +69 more
$0 sold by 22 investors
Millennium Management LLCStempoint Capital LP +20 more
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

Bright Minds Biosciences Inc. (DRUG) institutional activity · 93

Investor Type Est. change Change Δ Own Date
Vestal Point Capital, LP · New
Change +492K Date Q1 2026
Vestal Point Capital, LP New· Q1 2026 +492K Q1 2026
Deerfield Management Company, L.P. · New
Change +283K Date Q1 2026
Deerfield Management Company, L.P. New· Q1 2026 +283K Q1 2026
Ra Capital Management, L.P. · New
Change +265K Date Q1 2026
Ra Capital Management, L.P. New· Q1 2026 +265K Q1 2026
BlackRock · Added
Change +228K Date Q1 2026
BlackRock Added· Q1 2026 +228K Q1 2026
Great Point Partners LLC · New
Change +220K Date Q1 2026
Great Point Partners LLC New· Q1 2026 +220K Q1 2026
Braidwell LP · Added
Change +215K Date Q1 2026
Braidwell LP Added· Q1 2026 +215K Q1 2026
Driehaus Capital Management LLC · Added
Change +163K Date Q1 2026
Driehaus Capital Management LLC Added· Q1 2026 +163K Q1 2026
Millennium Management LLC · Reduced
Change −142K Date Q1 2026
Millennium Management LLC Reduced· Q1 2026 −142K Q1 2026
Janus Henderson Group PLC · Added
Change +128K Date Q1 2026
Janus Henderson Group PLC Added· Q1 2026 +128K Q1 2026
Wellington Management Group LLP · Added
Change +123K Δ Own +898.5% Date Q1 2026
Wellington Management Group LLP Added· Q1 2026 +123K +898.5% Q1 2026
Adage Capital Partners Gp, L.L.C. · Added
Change +100K Date Q1 2026
Adage Capital Partners Gp, L.L.C. Added· Q1 2026 +100K Q1 2026
Stempoint Capital LP · Exited
Change −97K Δ Own −100.0% Date Q1 2026
Stempoint Capital LP Exited· Q1 2026 −97K −100.0% Q1 2026
Balyasny Asset Management L.P. · Added
Change +72K Date Q1 2026
Balyasny Asset Management L.P. Added· Q1 2026 +72K Q1 2026
Perceptive Advisors LLC · Reduced
Change −72K Date Q1 2026
Perceptive Advisors LLC Reduced· Q1 2026 −72K Q1 2026
Seven Grand Managers, LLC · Added
Change +70K Date Q1 2026
Seven Grand Managers, LLC Added· Q1 2026 +70K Q1 2026
Data through Q1 2026 · filed Jun 4, 2026
15 of 93

Famous investor activity in Bright Minds Biosciences Inc. (DRUG)

Bright Minds Biosciences Inc. (DRUG) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Cormorant Asset Management, LP · Other Sell −$9.8M
Price $89.50 Qty −109K Owned 950K Trade date Apr 28, 2026 Filed date Apr 30, 2026
Cormorant Asset Management, LP Other Sell $89.50 −109K −$9.8M 950K Apr 28, 2026 Apr 30, 2026
1 of 1

Bright Minds Biosciences Inc. (DRUG) activist and large shareholders

What are Schedules 13D and 13G?

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
McDonald Ian 1.6M
% of shares outstanding 30.6% Filing date Feb 26, 2024
McDonald Ian 1.6M 30.6% Feb 26, 2024
McDonald Ian 1.4M
% of shares outstanding 23.7% Filing date Nov 5, 2024
McDonald Ian 1.4M 23.7% Nov 5, 2024
Cormorant Asset Management, LP 1.1M
% of shares outstanding 17.3% Filing date Nov 6, 2024
Cormorant Asset Management, LP 1.1M 17.3% Nov 6, 2024
Janus Henderson Group PLC 1.3M
% of shares outstanding 13.1% Filing date May 15, 2026
Janus Henderson Group PLC 1.3M 13.1% May 15, 2026
Cormorant Asset Management, LP 950K
% of shares outstanding 9.7% Filing date Apr 30, 2026
Cormorant Asset Management, LP 950K 9.7% Apr 30, 2026
Point72 Asset Management, L.P. 435K
% of shares outstanding 9.7% Filing date Oct 23, 2024
Point72 Asset Management, L.P. 435K 9.7% Oct 23, 2024
Perceptive Advisors LLC 430K
% of shares outstanding 9.6% Filing date Oct 16, 2024
Perceptive Advisors LLC 430K 9.6% Oct 16, 2024
Commodore Capital LP 400K
% of shares outstanding 9.0% Filing date Oct 25, 2024
Commodore Capital LP 400K 9.0% Oct 25, 2024
8 of 15

Bright Minds Biosciences Inc. (DRUG) ownership FAQ

Who owns DRUG?

93 reporting institutions disclosed DRUG position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.